Global X Genomics & Biotechnology ETF (GNOM)
NASDAQ: GNOM · Real-Time Price · USD
9.18
-0.03 (-0.28%)
At close: Aug 29, 2025, 4:00 PM
9.17
-0.01 (-0.16%)
After-hours: Aug 29, 2025, 5:47 PM EDT
GNOM Holdings Information
GNOM is an equity ETF with a total of 48 individual holdings. The top holdings are Alnylam Pharmaceuticals stock at 6.79%, Avidity Biosciences at 5.75%, Guardant Health at 5.13%, CRISPR Therapeutics AG at 5.00%, and Illumina at 4.72%.
Total Holdings
48
Top 10 Percentage
46.85%
Asset Class
Equity
ETF Category
Health
Assets
46.25M
PE Ratio
n/a
Sector Allocation
Top 25 Holdings
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | ALNY | Alnylam Pharmaceuticals, Inc. | 6.79% |
| 2 | RNA | Avidity Biosciences, Inc. | 5.75% |
| 3 | GH | Guardant Health, Inc. | 5.13% |
| 4 | CRSP | CRISPR Therapeutics AG | 5.00% |
| 5 | ILMN | Illumina, Inc. | 4.72% |
| 6 | NTRA | Natera, Inc. | 4.10% |
| 7 | QGEN | Qiagen N.V. | 3.96% |
| 8 | TECH | Bio-Techne Corporation | 3.93% |
| 9 | WGS | GeneDx Holdings Corp. | 3.82% |
| 10 | LEGN | Legend Biotech Corporation | 3.64% |
| 11 | BMRN | BioMarin Pharmaceutical Inc. | 3.38% |
| 12 | MRNA | Moderna, Inc. | 3.35% |
| 13 | BNTX | BioNTech SE | 3.22% |
| 14 | ARWR | Arrowhead Pharmaceuticals, Inc. | 3.03% |
| 15 | RARE | Ultragenyx Pharmaceutical Inc. | 2.95% |
| 16 | VRTX | Vertex Pharmaceuticals Incorporated | 2.89% |
| 17 | HKG: 1548 | Genscript Biotech Corporation | 2.88% |
| 18 | VCYT | Veracyte, Inc. | 2.74% |
| 19 | A | Agilent Technologies, Inc. | 2.16% |
| 20 | LON: AZN | AstraZeneca PLC | 2.11% |
| 21 | GILD | Gilead Sciences, Inc. | 1.92% |
| 22 | TWST | Twist Bioscience Corporation | 1.78% |
| 23 | BMY | Bristol-Myers Squibb Company | 1.75% |
| 24 | TXG | 10x Genomics, Inc. | 1.73% |
| 25 | BEAM | Beam Therapeutics Inc. | 1.72% |
As of Aug 28, 2025